BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2546748)

  • 1. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid modulation of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Morii N
    Clin Exp Hypertens A; 1988; 10 Suppl 1():361-7. PubMed ID: 3243002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of leumorphin on vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Endocrinology; 1988 Mar; 122(3):985-90. PubMed ID: 3342763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits.
    Fukuhara M; Matsumura K; Abe I; Fujishima M
    Hypertens Res; 1998 Jun; 21(2):89-95. PubMed ID: 9661804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin release in response to hypovolaemia in the conscious rat and the effect of opioid and aminergic receptor antagonists.
    Peysner K; Forsling ML
    J Physiol Pharmacol; 1991 Sep; 42(3):317-26. PubMed ID: 1686565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by gamma-aminobutyric acid in conscious rats.
    Otake K; Kondo K; Oiso Y
    Neuroendocrinology; 1991 Aug; 54(2):170-4. PubMed ID: 1766553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
    Ishikawa S; Schrier RW
    J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects.
    Aubert JF; Burnier M; Waeber B; Nussberger J; Brunner HR
    J Pharmacol Exp Ther; 1987 Nov; 243(2):681-5. PubMed ID: 3681699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opioid peptide inhibition of the central actions of angiotensin.
    Summy-Long JY; Keil LC; Deen K; Rosella L; Severs WB
    J Pharmacol Exp Ther; 1981 Jun; 217(3):619-29. PubMed ID: 6262492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Hypertension; 1988 Feb; 11(2 Pt 2):I80-3. PubMed ID: 3346067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats.
    Sugimura Y; Murase T; Ishizaki S; Tachikawa K; Arima H; Miura Y; Usdin TB; Oiso Y
    Endocrinology; 2003 Jul; 144(7):2791-6. PubMed ID: 12810532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa-opioid modulation of vasopressin secretion in conscious rats.
    Wells T; Forsling ML
    J Endocrinol; 1991 Jun; 129(3):411-6. PubMed ID: 1648591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracarotid administration of morphine and naloxone on plasma vasopressin levels and blood pressure in the dog.
    Rockhold RW; Crofton JT; Wang BC; Share L
    J Pharmacol Exp Ther; 1983 Feb; 224(2):386-90. PubMed ID: 6822963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on vasopressin release of microinjection of angiotensin II into the paraventricular nucleus of conscious rats.
    Shoji M; Share L; Crofton JT
    Neuroendocrinology; 1989 Sep; 50(3):327-33. PubMed ID: 2797385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation for roles of periventricular cholinoceptors in vasopressin secretion in response to angiotensin II and an osmotic stimulus.
    Yamaguchi K; Hama H
    Brain Res; 1989 Sep; 496(1-2):345-50. PubMed ID: 2804646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion.
    Yamaguchi K; Watanabe K
    Brain Res Bull; 2005 Jul; 66(1):59-69. PubMed ID: 15925145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate regulation of angiotensin-induced drinking and vasopressin release.
    Summy-Long JY; Keil LC; Deen K; Severs WB
    J Pharmacol Exp Ther; 1981 Jun; 217(3):630-7. PubMed ID: 7229996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of forebrain GABA receptors in controlling vasopressin secretion and related phenomena under basal and hyperosmotic circumstances in conscious rats.
    Yamaguchi K; Yamada T
    Brain Res Bull; 2008 Sep; 77(1):61-9. PubMed ID: 18639747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.